Stock Events

Ultragenyx Pharmaceutical (RARE) Q3 2024 Earnings

1AugConfirmed
Q4 2023
Q1 2024
Q2 2024
Q3 2024
-2.23
-1.99
-1.76
-1.52

Details

Expected EPS
-1.660679
Actual EPS
-1.52
Surprise EPS
0.14
Surprise Percent
+8.47%

Description

Ultragenyx Pharmaceutical (RARE) has reported earnings of -1.52 per share for Q3 2024.

0 Comments

Share your thoughts